文献速递胸部CT

眼见为实:CT在慢性阻塞性肺疾病表型分析中的应用

Seeing is believing-on the utility of CT in phenotyping chronic obstructive pulmonary disease.
PubMed 文献 · Br J Radiol · 2026-01-01

本文综述胸部CT在慢性阻塞性肺疾病(COPD)表型分析中的生物标志物演变,从传统阈值法量化肺气肿和气道尺寸,到纹理分析、图像配准及深度学习自动提取标志物,并讨论数据集异质性、模型泛化性和临床可解释性等挑战及未来潜力。

要点

  • 胸部CT可量化COPD相关的肺实质、气道、血管和裂隙等多结构异常。
  • 深度学习已能自动提取生物标志物,提升表型刻画和结局预测的精度。
  • 数据集异质性、模型泛化性和临床可解释性仍是当前挑战。

核心结论

  • 胸部CT生物标志物在COPD表型分析中不断演变,深度学习等方法提升了表型刻画和结局预测精度,但数据集异质性、模型泛化性和临床可解释性等挑战仍存,未来有望用于个性化COPD管理。

研究设计与样本

  • 综述,探讨胸部CT生物标志物在COPD中的演变,涵盖传统阈值法、纹理分析、图像配准和深度学习方法。

关键影像表现/征象

  • 传统阈值法用于量化肺气肿和气道尺寸。
  • 纹理分析用于肺组织亚型划分。
  • 基于图像配准的生物标志物实现空间感知的局部异常分析。
  • 深度学习实现自动化生物标志物提取,提升表型刻画和结局预测精度。

局限性

  • 数据集异质性仍是挑战。
  • 模型泛化性仍是挑战。
  • 临床可解释性仍是挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with complicated structural and functional impairments. For decades now, chest CT has been used to quantify various abnormalities related to COPD. More recently, with the newer data-driven approaches, biomarker development and validation have evolved rapidly. Studies now target multiple anatomical structures including lung parenchyma, the airways, the vasculature, and the fissures to better characterize COPD. This review explores the evolution of chest CT biomarkers in COPD, beginning with traditional thresholding approaches that quantify emphysema and airway dimensions. We then highlight some of the texture analysis efforts that have been made over the years for subtyping lung tissue. We also discuss image registration-based biomarkers that have enabled spatially-aware mechanisms for understanding local abnormalities within the lungs. More recently, deep learning has enabled automated biomarker extraction, offering improved precision in phenotype characterization and outcome prediction. We highlight the most recent of these approaches as well. Despite these advancements, several challenges remain in terms of dataset heterogeneity, model generalizability, and clinical interpretability. This review lastly provides a structured overview of these limitations and highlights future potential of CT biomarkers in personalized COPD management.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Awan HA, Chaudhary MFA, Reinhardt JM, et al. Seeing is believing-on the utility of CT in phenotyping chronic obstructive pulmonary disease. Br J Radiol. 2026. PMID: 40650927. doi:10.1093/bjr/tqaf160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。